Better survival and less cardiac morbidity in female patients with thalassemia major: A review of the literature

Annals of the New York Academy of Sciences

Volumn 1202, Issue , 2010, Pages 129-133

  Marsella, Maria ^a   Pepe, Alessia ^b   Borgna Pignatti, Caterina ^a  

^a Department of Clinical and Experimental Medicine ^*  (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

gender; MRI T2; oxidative stress; survival; thalassemia

Indexed keywords

ESTROGEN; FERRITIN; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TESTOSTERONE;

CARDIAC IRON; CLINICAL ASSESSMENT; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; EPICARDIUM; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART VENTRICLE WALL; HUMAN; IMMUNE SYSTEM; IRON OVERLOAD; LIFE EXPECTANCY; MALE; MITOCHONDRION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; OXIDATIVE STRESS; SEX DIFFERENCE; SICKLE CELL ANEMIA; THALASSEMIA MAJOR;

EID: 77955881894     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05588.x     Document Type: Conference Paper

References (24)

1. Chouliaras, G., C.T. Yiannoutsos, V. Berdoukas & V. Ladis. 2009. Cardiac related death in thalassaemia major: time trend and risk factors in a large GreekUnit. Eur. J.Haematol. 82: 381-387.
2. Borgna-Pignatti, C., S. Rugolotto, P. De Stefano, et al. 2004. Survival and complications in patients with thalassemiamajor treated with transfusion and deferoxamine. Haematologica 89: 1187-1193.
3. Telfer, P.T., F. Warburton, S. Christou, et al. 2009. Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone. Haematologica 94: 1777-1778.
4. Buja, L.M. &W.C. Roberts. 1971. Iron in the heart. Etiology and clinical significance. Am. J. Med. 51: 209-221.
5. Cohen, A.R., R. Galanello, D.J. Pennell, et al. 2004. Thalassemia. Hematol. Am. Soc. Hematol. Educ. Program 14-34.
6. Breuer, W., C. Hershko & Z.I. Cabantchik. 2000. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus. Sci. 23: 185-192.
7. Ramazzotti, A., A. Pepe, V. Positano, et al. 2009. Multicenter validation of the magnetic resonance T2- technique for segmental and global quantification of myocardial iron. J. Magn. Reson. Imaging 30: 62-68.
8. Meloni, A., A. Ramazzotti, V. Positano, et al. 2009. Evaluation of a web-based network for reproducible T2- MRI assessment of iron overload in thalassemia. Int. J. Med. Inf. 78: 503-512.
9. Pepe A, V. Positano, M.F. Santarelli, et al. 2006. Multislice multiecho T2- cardiovascular magnetic resonance for detection of the heterogeneous distribution ofmyocardial iron overload. J. Magn. Reson. Imaging 23: 662-668.
10. Marsella,M, C. Borgna-Pignatti, A.Meloni, et al. 2010. Cardiac iron loading measured bymultislicemultiecho T2- MRI and cardiac disease in male and female patients with thalassemia major. In Press.
11. Platt, O.S., D.J. Brambilla, W.F. Rosse, et al. 1994. Mortality in sickle cell disease. Life expectancy and risk factors for early death.N. Engl. J. Med. 330: 1639-1644.
12. Shankar, S.M., P.G. Arbogast, E. Mitchel, et al. 2005. Medical care utilization and mortality in sickle cell disease: a population-based study. Am. J. Hematol. 80: 262-270.
13. Wierenga, K.J., I.R.Hambleton &N.A. Lewis. 2001. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic based population study. Lancet 357: 680-683.
14. Kotila, T.R. & W.A. Shokunbi. 2001. Survival advantage in female patients with sickle cell anaemia. East Afr.Med. J . 78: 373-375.
15. Platt, O.S. 2000. Sickle cell anemia as an inflammatory disease. J. Clin. Invest. 106: 337-338.
16. Kaul, D.K. & R.P. Hebbel. 2000. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J. Clin. Invest. 106: 411-420.
17. Austad, S.N. 2006. Why women live longer than men: sex differences in longevity. Gend. Med. 3: 79-92.
18. Bonneux, L.G., C.C. Huisman & J.A. de Beer. 2010.Mortality in 272 European regions, 2002-2004. An update. Eur. J. Epidemiol. 25: 77-85.
19. Vina, J., C. Borr̀as, J. Gambini, et al. 2005. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett. 579: 2541-2545.
20. Shalev,H., J.Kapelushnik,A.Moser, et al. 2007.Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am. J. Hematol. 82: 199-202.
21. Gerschman, R., D.L. Gilbert, S.W. Nye, et al. 1954. Oxygen poisoning and X irradiation: a mechanism in common. Science 119: 623-626.
22. Harman, D. 1956. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11: 298-300.
23. Miquel, J., A.C. Economos, J. Fleming & J.E. Johnson. 1980. Mitochondrial role in cell aging. Exp. Gerontol. 15: 575-591.
24. Proteggente, A.R., T.G. England, A. Rehman, et al. 2002. Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals. Free Radic. Res. 36: 157-162.